Abstract
Turner syndrome (TS) is a genetic condition occurring in females characterized by partial or complete loss of the second X chromosome resulting in a collection of clinical findings being short stature and primary ovarian insufficiency the hallmarks. However, TS may also involve other complaints including lymphedema, autoimmune diseases, metabolic diseases, cardiac, kidney and bone anomalies, hearing loss, and neurocognitive difficulties which lead to psychosocial and educational inadaptation. Optimizing health care is crucial to allow these individuals succeed in their full potential. This article will provide a review of the current best practice management recommendations for individuals with TS in regard to diagnosis, treatment of short stature, and estrogen supplementation, addressing psychosocial issues, as well screening for other comorbidities. Early identification of TS permits the appropriate screening assessments and well-timed treatment intervention. A multidisciplinary approach with a well-organized transition to adult follow-up health care is required to improve care delivery for this population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ros C, Serra A, Balasch J, Margarit E, Castelo-Branco C. Comparative cytogenetic analysis in two tissues with different lineage in Turner’s syndrome patients: correlation with phenotype. Gynecol Endocrinol. 2014;30(4):282–6.
Bondy CA, Turner T, Consensus S, et al. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2014;92:10–25.
Saikia UK, Sarma D, Yadav Y. Delayed presentation of Turner syndrome: challenge to optimal management. J Hum Reprod Sci. 2017;10(4):297–301.
Davenport M. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95:1487–95.
Marin A, Weir-McCall JR, Webb DJ, et al. Imaging of cardiovascular risk in patients with Turner’s syndrome. Clin Radiol. 2015;70:803–14.
Mortensen KH, Gopalan D, Andersen NH, et al. Multimodality cardiac imaging in Turner syndrome. Cardiol Young. 2016;26:831–41.
Castelo-Branco C. Management of Turner syndrome in adult life and beyond. Maturitas. 2014;79(4):471–5.
Donalson MDC, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child. 2006;91:513–20.
Devernay M, Ecosse E, Coste J, Carel JC. Determinants of medical care for young women with Turner Syndrome. J Clin Endocrinol Metab. 2009;94:3408–13.
Gravholt C. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol. 2004;151:657–87.
Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner’s syndrome in adulthood. Endocr Rev. 2003;23:120–40.
Conway GS. The impact and management of Turner’s syndrome in adult life. Best Pract Res Clin Endocrinol Metab. 2002;16:243–61.
Stockholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91:3897–902.
Apperley L, Das U, Ramakrishnan R, Dharmaraj P, Blair J, Didi M, Senniappan S. Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study. Int J Pediatr Endocrinol. 2018;2018:4.
Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:1–70.
Ros C, Castelo-Branco C. Management of Turner’s syndrome in adult life: case-series and systematic review. Gynecol Endocrinol. 2012;28(9):726–32.
Bianco SDC, Kaiser UB. The genetic and molecular basis of idiophatic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009;5:569–76.
Shankar RK, Backeljauw PF. Current best practice in the management of Turner syndrome. Ther Adv Endocrinol Metab. 2018;9(1):33–40.
Oliveira CS, Alves C. The role of the SHOX gene in the pathophysiology of Turner syndrome. Endocrinol Nutr. 2011;58:433–42.
Quigley CA, Crowe BJ, Anglin DG, et al. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab. 2002;87:2033–41.
Baxter L, Bryant J, Cave CB, et al. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev. 2007;(1):CD003887.
Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner’s syndrome. N Engl J Med. 2011;364:1230–42.
van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88:1119–25.
Davenport ML, Crowe BJ, Travers SH, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multi-center trial. J Clin Endocrinol Metab. 2007;92:3406–16.
Stephure DK, Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab. 2005;90:3360–6.
Bell J, Parker KL, Swinford RD, et al. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010;95:167–77.
Darendeliler F, Karagiannis G, Wilton P. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database. Horm Res. 2007;68(Suppl.5):41–7.
Wooten N, Bakalov VK, Hill S, et al. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab. 2008;93:2109–14.
Cutfield WS, Wilton P, Bennmarker H, et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet. 2000;355:610–3.
Sas TC, Gault EJ, Bardsley MZ, et al. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use. Horm Res Paediatr. 2014;81:289–97.
Menke LA, Sas TC, de Muinck Keizer-Schrama SM, et al. Efficacy and safety of oxandrolone in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab. 2010;95:1151–60.
Pasquino AM, Passeri F, Pucarelli I, et al. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab. 1997;82:1810–3.
Bannink EM, van Sassen C, van Buurent S, de Jong FH, Lequin M, Mulder PGH. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol (Oxf). 2009;70:265–73.
Lunding SA, Aksglaede L, Anderson RA, et al. AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner Syndrome patients. J Clin Endocrinol Metab. 2015;100:1030–8.
Castelo-Branco C, León M, Durán M, Balasch J. Follicle-stimulating hormones does not directly regulate bone mass in human beings: evidence from nature. Fertil Steril. 2008;90:2211–6.
Ross J, Roentgen D, Zinn A. Cognition and the sex chromosomes: studies in Turner syndrome. Horm Res. 2006;65:47–56.
Lim HH, Kil HR, Koo SH. Incidence, puberty, and fertility in 45,X/47,XXX mosaicism: report of a patient and a literature review. Am J Med Genet A. 2018;176(4):1029.
Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod. 2005;5:1418–21.
Foudila T, Soderstrom-Anttila V, Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod. 1999;14:532–5.
Breuil V, Euler-Ziegler L. Gonadal dysgenesis and bone metabolism. Joint Bone Spine. 2001;68:26–33.
Bakalov V, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord. 2008;9:145–51.
Sass TC, De Muinck SM, Stijnen T, Asarfi A, Van Leeuwen WJ, Van Teunenbroek A, Van Rijn RR, Drop SL. A longitudinal study on bone mineral density until adulthood in girls with Turner’s syndrome participating in growth hormone injection frequency-response trial. Clin Endocrinol (Oxf). 2000;52:531–6.
Schoemaker MJ, Swerdlow AJ, Higgins CD, et al. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008;93:4735–42.
Bondy CA. Heart disease in Turner syndrome. Minerva Endocrinol. 2007;32:245–61.
Mortensen KH, Andersen NH, Gravholt CH. Cardiovascular phenotype in Turner syndrome-integrating cardiology, genetics and endocrinology. Endocr Rev. 2012;33:677–714.
Donato B, Ferreira MJ. Cardiovascular risk in Turner syndrome. Rev Port Cardiol. 2018;37(7):607–21.
Thomas J, Yetman AT. Management of cardiovascular disease in Turner syndrome. Expert Rev Cardiovasc Ther. 2009;7:1631–41.
Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, et al. The DNA sequence of the human X chromosome. Nature. 2005;434:325–37.
O’Gorman CS, Syme C, Lang J, Bradley TJ, et al. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome. Clin Endocrinol (Oxf). 2013;78:907–13.
Akyrek N, Atabek ME, Eklioglu BS, et al. The relationship of periaortic fat thickness and cardiovascular risk factors in children with Turner syndrome. Pediatr Cardiol. 2015;36:925–9.
Berdahl LD, Wenstrom KD, Hanson JW. Web neck anomaly and its association with congenital heart disease. Am J Med Genet. 1995;56:304–7.
Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young. 2006;16:430–6.
Conway GS, Band M, Doyle J, Davies MC. How do you monitor the patient with Turner’s syndrome in adulthood? Clin Endocrinol (Oxf). 2010;73:696–9.
Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med. 2004;351:1227–38.
Hong D, Scaletta KJ, Kesler S. Cognitive profile of Turner syndrome. Dev Disabil Res Rev. 2009;15:270–8.
Green T, Bade SS, Chromik LC, et al. Elucidating X chromosome influences on attention deficit hyperactivity disorder and executive function. J Psychiatr Res. 2015;68:217–25.
Mazzocco MM. The cognitive phenotype of Turner syndrome: specific learning disabilities. Int Congr Ser. 2006;1298:83–92.
Nijhuis-van der Sanden MW, Eling PA, Otten BJ. A review of neuropsychological and motor studies in Turner Syndrome. Neurosci Biobehav Rev. 2003;27:329–38.
McCauley E, Feuillan P, Kushner H, et al. Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr. 2001;22:360–5.
Sheaffer AT, Lange E, Bondy CA. Sexual function in women with Turner syndrome. J Womens Health (Larchmt). 2008;17(1):27–33.
Cardoso G, Daly R, Haq NA, et al. Current and lifetime psychiatric illness in women with Turner syndrome. Gynecol Endocrinol. 2004;19(6):313–9.
Garrido Oyarzun MF, Castelo-Branco C. Sexuality and quality of life in congenital hypogonadism. Gynecol Endocrinol. 2016;32(12):947–50.
Ros C, Alobid I, Balasch J, et al. Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. Am J Obstet Gynecol. 2013;208(6):484–6.
Carel JC, Elie C, Ecosse E, et al. Self-esteem and social adjustment in young women with Turner syndrome—influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab. 2006;91(8):2972–9.
Chadwick PM, Smyth A, Liao LM. Improving self-esteem in women diagnosed with Turner syndrome: results of a pilot intervention. J Pediatr Adolesc Gynecol. 2014;27:129–32.
Heilbronner RL, Sweet JJ, Attix DK, et al. Official position of the American Academy of Clinical Neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts. Clin Neuropsychol. 2010;24:1267–78.
Ros C, Tercero A, Alobid I, Balasch J, Santamaria J, Mullol J, Castelo-Branco C. Hearing loss in adult women with Turner's syndrome and other congenital hypogonadisms. Gynecol Endocrinol. 2014;30(2):111–6.
Verver EJ, Freriks K, Thomeer HG, Huygen PL, Pennings RJ, Alfen-van der Velden AA, Timmers HJ, Otten BJ, Cremers CW, Kunst HP. Ear and hearing problems in relation to karyotype in children with Turner syndrome. Hear Res. 2011;275(1–2):81–8.
Kubba H, Smyth A, Wong SC, Mason A. Ear health and hearing surveillance in girls and women with Turner’s syndrome: recommendations from the Turner’s Syndrome Support Society. Clin Otolaryngol. 2017;42(3):503–7.
Hederstierna C, Hultcrantz M, Rosenhall U. A longitudinal study of hearing decline in women with Turner syndrome. Acta Otolaryngol. 2009;129:1434–41.
Bergamaschi R, Bergonzoni C, Mazzanti L, Scarano E, Mencarelli F, Messina F, Rosano M, Iughetti L, Cicognani A. Hearing loss in Turner syndrome: results of a multicentric study. J Endocrinol Invest. 2008;31(9):779–83.
Hall JE, Richter GT, Choo DI. Surgical management of otologic disease in pediatric patients with Turner syndrome. Int J Pediatr Otorhinolaryngol. 2009;73(1):57–65.
Hederstierna C, Hultcrantz M, Rosenhall U. Estrogen and hearing from a clinical point of view; characteristics of auditory function in women with Turner syndrome. Hear Res. 2009;252:3–8.
Parkin M, Walker P. Hearing loss in Turner syndrome. Int J Pediatr Otorhinolaryngol. 2009;73:243–7.
Mortensen KH, Cleemann L, Hjerrild BE, et al. Increased prevalence of autoimmunity in Turner syndrome—influence of age. Clin Exp Immunol. 2009;156:205–10.
Grossi A, Crino A, Luciano R, Lombardo A, Cappa M, Fierabracci A. Endocrine autoimmunity in Turner syndrome. Ital J Pediatr. 2013;39:79.
Gravholt CH. Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab. 2005;1:41–52.
Bronshtein M, Zimmer EZ, Blazer S. A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol. 2003;188:1016–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Castelo-Branco, C., Naumova, I. (2019). Turner Syndrome: Primary Amenorrhea from Adolescence to Aging. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-13936-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13935-3
Online ISBN: 978-3-030-13936-0
eBook Packages: MedicineMedicine (R0)